Abstract:To explore options of microinvasive surgery for renal calculi within 3 cm. Methods We retrospectively analyzed the clinical data of 70 patients with renal calculi who met the inclusion criteria from May 2016 to May 2018, including 34 patients in the PCNL group and 36 patients in the FURL group. Then evaluate the clinical efficacy of the two surgical methods for treating renal calculi by comparing the operative time, postoperative hospital stay, surgical bleeding rate, stone clearance rate, postoperative C-reactive protein (CRP) elevation rate and other observational parameters. Results There was no statistical significance in general data (gender, age, maximum diameter of stone), operation time, stone clearance rate and proportion of fever after surgery between the two groups of patients with renal calculi (P > 0.05). The postoperative hospital stay in the PCNL group was longer than that in the FURL group, they were (9.06 ± 2.35) day and (3.94 ± 1.26) day, respectively. The surgical bleeding rate in the PCNL group, and the postoperative C-reactive protein (CRP) increase rate were higher than those in the FURL group. The difference between the two groups was statistically significant (P < 0.05). Conclusion For the two groups of minimally invasive treatments for renal calculi within 3 cm. Percutaneous nephrolithotomy (PCNL) has the advantages of less trauma, definite curative effect. However, the risk of intraoperative and postoperative bleeding, postoperative infection may be associated with the course of treatment. The flexible ureteroscope lithotripsy (FURL) treatment of renal calculi is almost non-invasive. And it has the advantages of less bleeding, definite curative effect, lower postoperative infection rate and rapid postoperative recovery. In the case that both surgical methods can be used as an alternative, flexible ureteroscope lithotripsy (FURL) has a certain advantage in treatment of renal calculi within 3 cm. It is worth recommending.